Fidelity Investments’s NantHealth, Inc NH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-16
Closed -$32 5700
2023
Q1
$32 Buy
+16
New +$47 ﹤0.01% 5042
2022
Q3
Sell
-66
Closed 5589
2022
Q2
$0 Sell
66
-83
-56% -$775 ﹤0.01% 5692
2022
Q1
$2K Buy
+149
New +$1.9K ﹤0.01% 4745
2018
Q2
Sell
-6,703
Closed -$307K 2741
2018
Q1
$307K Sell
6,703
-4,435
-40% -$223K ﹤0.01% 2572
2017
Q4
$510K Sell
11,138
-6
-0.1% -$318 ﹤0.01% 2523
2017
Q3
$689K Sell
11,144
-119
-1% -$6.97K ﹤0.01% 2453
2017
Q2
$715K Sell
11,263
-320
-3% -$17.7K ﹤0.01% 2470
2017
Q1
$862K Sell
11,583
-29,980
-72% -$3.34M ﹤0.01% 2469
2016
Q4
$6.2M Hold
41,563
﹤0.01% 2128
2016
Q3
$8.2M Sell
41,563
-18,437
-31% -$3.39M ﹤0.01% 2062
2016
Q2
$11.3M Buy
+60,000
New +$13.1M ﹤0.01% 1914

Fidelity Investments's NH Position: Q2 2023 in Review

Fidelity Investments sold out of NantHealth, Inc (NH) in Q2 2023, closing a stake of 16 shares — an estimated $32 sold.

Fidelity Investments first reported a position in NH in Q2 2016 and held it in 11 quarters. The position peaked at $11.3M in Q2 2016. 0 funds tracked by Wall St. Rank hold NH as of Q2 2023.

  • Fidelity Investments reported no remaining NantHealth, Inc position as of Q2 2023 after selling out during the quarter.
  • Fidelity Investments sold 16 NantHealth, Inc shares in Q2 2023, an estimated $32.
  • Fidelity Investments first reported a position in NantHealth, Inc in Q2 2016 and held it in 11 quarters.
  • Fidelity Investments's NantHealth, Inc position peaked at $11.3M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2023.

Based on Fidelity Investments's 13F filing for Q2 2023, filed 11 Aug 2023.